Hartmut Koeppen

9PUBLICATIONS
61CO-AUTHORS
Tumour immunologyInnate immunityPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Surface water quality processes and contaminated sediment assessment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 05, 2025
IL-27 elicits a cytotoxic CD8+ T cell program to enforce tumour control.

Béatrice Bréart, Katherine Williams, Stellanie Krimm

|Jan 24, 2025
Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer.

Matthew D Galsky, Mark Kockx, Juliette Roels

|Mar 25, 2024
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy.

Xiao Li, Jeffrey Eastham, Jennifer M Giltnane

|Dec 04, 2023
Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas.

Stephen J Schuster, Ling-Yuh Huw, Christopher R Bolen

|Aug 01, 2022
Disruption of stem cell niche-confined R-spondin 3 expression leads to impaired hematopoiesis.

Antonina V Kurtova, Melanie Heinlein, Simon Haas

|Apr 20, 2022
Distinct resistance mechanisms arise to allosteric vs. ATP-competitive AKT inhibitors.

Kristin M Zimmerman Savill, Brian B Lee, Jason Oeh

Pageof 2

Frequent Collaborators

3 joint publications

Mark M Kockx

2 joint publications

Ira Mellman

1 joint publications

Benjamin Haley

1 joint publications

Christiaan Klijn